The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Matinas Biopharma Holdings Inc’s current trading price is -96.74% away from its 52-week high, while its distance from the 52-week low is 46.44%. The stock’s price range for this period has been between $0.48 and $21.50 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 13.03 million for the day, a number notably higher than the average daily volume of 0.29 million over the last three months.
Matinas Biopharma Holdings Inc saw a rather unpredictable run in, in terms of market performance. The company’s stock reached its highest point at $21.50 on 03/22/24, while the lowest price for the same duration was marked at $0.48 on 12/30/24.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Matinas Biopharma Holdings Inc (MTNB) has experienced a quarterly decline of -77.99% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 3.56M and boasts a workforce of 32 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 2.2079, with a change in price of -6.9500. Similarly, Matinas Biopharma Holdings Inc recorded 334,212 in trading volume during the last 100 days, posting a change of -90.85%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for MTNB stands at 0.19. Similarly, the long-term debt-to-equity ratio is also 0.15.
MTNB Stock Stochastic Average
As of today, Matinas Biopharma Holdings Inc’s raw stochastic average for the last 50 days stands at 23.32%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 23.32%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 16.94% and 16.87%, respectively.
MTNB Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The index has shown a price gain of 37.25% this year. Over the last six months, there has been a stronger performance of -91.71%. The price of MTNB fallen by 18.64% during the last 30 days period. For the last 5-days stocks have slided -4.63%.